Endothelial dysfunction is a hallmark of cardiovascular disease and a target for both statins and vitamin D. Statins enhance endothelial nitric oxide synthase (eNOS) activity, improving nitric oxide (NO) bioavailability, which leads to vasodilation and vascular homeostasis [16,33]. The gene discussed is NOS3; the disease is cardiovascular disorder.